Simplex Trading’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-6,900
Closed 10330
2023
Q4
$0 Buy
6,900
+5,278
+325% +$523 ﹤0.01% 10250
2023
Q3
$0 Buy
+1,622
New +$467 ﹤0.01% 10238
2022
Q3
Sell
-1,598
Closed -$3.1K 11218
2022
Q2
$2K Buy
+1,598
New +$2.31K ﹤0.01% 9474
2022
Q1
Sell
-2,298
Closed -$3.29K 11711
2021
Q4
$2K Buy
+2,298
New +$3.73K ﹤0.01% 10099

Simplex Trading's RVLP Position: Q1 2024 in Review

Simplex Trading sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q1 2024, closing a stake of 6,900 shares.

Simplex Trading first reported a position in RVLP in Q4 2021 and held it in 4 quarters. The position peaked at $2K in Q2 2022. 0 funds tracked by Wall St. Rank hold RVLP as of Q1 2024.

  • Simplex Trading reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q1 2024 after selling out during the quarter.
  • Simplex Trading sold 6,900 RVL Pharmaceuticals plc Ordinary Shares shares in Q1 2024.
  • Simplex Trading first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q4 2021 and held it in 4 quarters.
  • Simplex Trading's RVL Pharmaceuticals plc Ordinary Shares position peaked at $2K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q1 2024.

Based on Simplex Trading's 13F filing for Q1 2024, filed 25 Apr 2024.